Metyor VG 1mg/500mg/0.2mg Tablet SR
Marketer
Cardimind Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Metyor VG 1mg/500mg/0.2mg Tablet SR
Metyor VG 1mg/500mg/0.2mg SR tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This treatment helps regulate blood glucose levels. Administer Metyor VG with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Primary Ingredients of Metyor VG 1mg/500mg/0.2mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased. A replacement text is needed to fulfill the request.
Uses of Metyor VG 1mg/500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Metyor VG 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Metyor VG 1mg/500mg/0.2mg Extended-Release tablet should be taken on an empty stomach.
Common Side effects of Metyor VG 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metyor VG 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Metyor VG 1mg/500mg/0.2mg Sustained-Release tablet on an empty stomach.
How Metyor VG 1mg/500mg/0.2mg Tablet SR works:
Each Metyor VG sustained-release tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metyor VG 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metyor VG 1mg/500mg/0.2mg sustained-release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential dangers before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release formulation of Metyor VG (1mg/500mg/0.2mg) is likely not safe for breastfeeding mothers. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Metyor VG 1mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be forgone. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Metyor VG 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction should generally begin with a reduced Metyor VG 1mg/500mg/0.2mg Tablet SR dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Metyor VG 1mg/500mg/0.2mg Tablet SR :
Should you forget a dose of Metyor VG 1mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metyor VG 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently